RAPID COMMUNICATION
Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds
Mirella Hansen de AlmeidaI,III, Joana Rodrigues DantasI,II,
, Bianca BaroneI,II, Fabiano Marcel SerfatyI,II, Rosane KupferII, Marta AlbernazIV, Maria Rocio BenckeIV, Lenita ZajdenvergI, Melanie RodackiI, José Egídio Paulo de OliveiraI
Corresponding author
I Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro (HUCFF), Nutrology Department, Rio de Janeiro/RJ, Brazil.
II State Institute of Diabetes and Endocrinology Luiz Capriglione (IEDE), Rio de Janeiro/RJ, Brazil.
III Air Force Central Hospital (HCA), Endocrinology Department, Rio de Janeiro/RJ, Brazil.
IV Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro (HUCFF), Nuclear Medicine Department, Rio de Janeiro/RJ, Brazil.
Read
2465
Timeswas read the article
1189
Total PDF
1276
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 52 | 75 | 127 |
| 2025 11 | 179 | 329 | 508 |
| 2025 10 | 85 | 174 | 259 |
| 2025 9 | 74 | 191 | 265 |
| 2025 8 | 62 | 31 | 93 |
| 2025 7 | 72 | 7 | 79 |
| 2025 6 | 44 | 5 | 49 |
| 2025 5 | 62 | 6 | 68 |
| 2025 4 | 61 | 6 | 67 |
| 2025 3 | 29 | 18 | 47 |
| 2025 2 | 32 | 9 | 41 |
| 2025 1 | 37 | 5 | 42 |
| 2024 12 | 44 | 11 | 55 |
| 2024 11 | 45 | 27 | 72 |
| 2024 10 | 34 | 25 | 59 |
| 2024 9 | 35 | 17 | 52 |
| 2024 8 | 49 | 21 | 70 |
| 2024 7 | 35 | 19 | 54 |
| 2024 6 | 40 | 18 | 58 |
| 2024 5 | 32 | 13 | 45 |
| 2024 4 | 15 | 7 | 22 |
| 2024 3 | 14 | 15 | 29 |
| 2024 2 | 14 | 17 | 31 |
| 2024 1 | 7 | 19 | 26 |
| 2023 12 | 7 | 13 | 20 |
| 2023 11 | 13 | 19 | 32 |
| 2023 10 | 18 | 23 | 41 |
| 2023 9 | 15 | 24 | 39 |
| 2023 8 | 9 | 7 | 16 |
| 2023 7 | 11 | 14 | 25 |
| 2023 6 | 8 | 18 | 26 |
| 2023 5 | 5 | 0 | 5 |
| 2023 4 | 4 | 0 | 4 |
| 2023 3 | 4 | 1 | 5 |
| 2023 2 | 1 | 0 | 1 |
| 2023 1 | 3 | 1 | 4 |
| 2022 12 | 25 | 4 | 29 |
Show all